Bentsen Gunnar, Stubhaug Audun, Eide Per K
Faculty of Medicine, Division of Anesthesiology and Intensive Care Medicine, Rikshospitalet University Hospital, University of Oslo, Oslo, Norway.
Crit Care Med. 2008 Aug;36(8):2414-9. doi: 10.1097/CCM.0b013e318180fe04.
A bolus infusion of 7.2% saline in 6% hydroxyethyl starch 200/0.5 (HS) attenuates static intracranial pressure (mean ICP) in subarachnoid hemorrhage patients. This study addressed how HS affects intracranial pulsatility, which is more indicative of intracranial compliance than static ICP.
Retrospective analysis of prospectively collected data.
Intensive care unit in a university hospital.
Sedated and mechanically ventilated patients suffering from spontaneous subarachnoid hemorrhage.
Twenty patients received an infusion of HS, mean 1.5 mL/kg. Static ICP was characterized by mean ICP and intracranial pulsatility by mean ICP wave amplitude, both parameters determined simultaneously during consecutive 6-sec time windows. We compared average values of these parameters during 15-min periods just before the infusion and after maximum effect was reached.
Mean ICP wave amplitude decreased 3.4 mm Hg from a baseline of 9.8 mm Hg, p < 0.0001. However, even though a target level of <15 mm Hg was reached for mean ICP in 65% of interventions, the target of <5 mm Hg for mean ICP wave amplitude was reached in only 30% of interventions. We found no correlation between changes in mean ICP wave amplitude and mean systemic arterial blood pressure wave amplitude, p = 0.27.
The results confirm that osmotherapy attenuates both static ICP (mean ICP) and pulsatile ICP (mean ICP wave amplitude). Most importantly, however, during the majority of HS infusions, the target value of mean ICP wave amplitude was not reached even though the targets for mean ICP and mean cerebral perfusion pressure were reached. This suggests that the intracranial compliance state was still unfavorable even though mean ICP and mean cerebral perfusion pressure had reached normal ranges. The reduction in intracranial pulsatility could not be explained by attenuation in arterial pulsatility because there was no correlation between ICP and arterial blood pressure wave amplitudes.
在蛛网膜下腔出血患者中,静脉推注7.2%盐水与6%羟乙基淀粉200/0.5(HS)可降低静态颅内压(平均颅内压)。本研究探讨了HS如何影响颅内搏动性,相较于静态颅内压,颅内搏动性更能反映颅内顺应性。
对前瞻性收集的数据进行回顾性分析。
大学医院重症监护病房。
因自发性蛛网膜下腔出血而接受镇静和机械通气的患者。
20例患者接受HS输注,平均剂量为1.5 mL/kg。静态颅内压以平均颅内压为特征,颅内搏动性以平均颅内压波幅为特征,这两个参数在连续的6秒时间窗内同时测定。我们比较了输注前15分钟和达到最大效应后这些参数的平均值。
平均颅内压波幅从基线的9.8 mmHg下降了3.4 mmHg,p < 0.0001。然而,尽管在65%的干预中平均颅内压达到了<15 mmHg的目标水平,但平均颅内压波幅<5 mmHg的目标仅在30%的干预中实现。我们发现平均颅内压波幅变化与平均体动脉血压波幅之间无相关性,p = 0.27。
结果证实,渗透压疗法可降低静态颅内压(平均颅内压)和搏动性颅内压(平均颅内压波幅)。然而,最重要的是,在大多数HS输注过程中,即使平均颅内压和平均脑灌注压达到了目标值,平均颅内压波幅的目标值仍未达到。这表明,即使平均颅内压和平均脑灌注压已达到正常范围,颅内顺应性状态仍然不佳。颅内搏动性的降低不能用动脉搏动性的减弱来解释,因为颅内压与动脉血压波幅之间无相关性。